Quoin Pharmaceuticals, Ltd. (QNRX) Tops Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts QNRX Hot Sheet
Join SI Premium – FREE
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q4 EPS of ($0.41), $0.10 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Green Dot and CommerceOne shareholders approve acquisition deal
- St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
